V030-6559 Screening compound: 3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-1-(morpholin-4-yl)propan-1-one

V030-6559 Screening compound: 3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-1-(morpholin-4-yl)propan-1-one
V030-6559 Screening compound: 3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-1-(morpholin-4-yl)propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-6559
3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-1-(morpholin-4-yl)propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-6559

Molecular Formula

C29H27N3O2S (C29 H27 N3 O2 S)

Compound Name

3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-1-(morpholin-4-yl)propan-1-one

IUPAC name

3-[6-(1-benzothiophen-2-yl)-2-(4-methylphenyl)imidazo[12-a]pyridin-3-yl]-1-(morpholin-4-yl)propan-1-one

SMILES

Cc(cc1)ccc1-c1c(CCC(N2CCOCC2)=O)n(cc(cc2)-c3cc(cccc4)c4s3)c2n1

InChI

InChI=1S/C29H27N3O2S/c1-20-6-8-21(9-7-20)29-24(11-13-28(33)31-14-16-34-17-15-31)32-19-23(10-12-27(32)30-29)26-18-22-4-2-3-5-25(22)35-26/h2-10,12,18-19H,11,13-17H2,1H3

InChI Key

TUSOUXDYDWLZFP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20494476

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

481.62

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.631

Distribution Coefficient, logD

5.615

Water Solubility, LogSw

-6.14

Polar Surface Area

33.003

Acid Dissociation Constant (pKa)

23.16

Base Dissociation Constant (pKb)

5.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.10

V030-6559 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V030-6559 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-6559?
Check Price and Availability of V030-6559, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-6559 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-6559
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-6559
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-6559 available by request